164 related articles for article (PubMed ID: 37496662)
1. A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer.
Sampayo-Cordero M; Miguel-Huguet B; Malfettone A; López-Miranda E; Gion M; Abad E; Alcalá-López D; Pérez-Escuredo J; Pérez-García JM; Llombart-Cussac A; Cortés J
Front Oncol; 2023; 13():1048242. PubMed ID: 37496662
[TBL] [Abstract][Full Text] [Related]
2. Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification.
Trapani D; Franzoi MA; Burstein HJ; Carey LA; Delaloge S; Harbeck N; Hayes DF; Kalinsky K; Pusztai L; Regan MM; Sestak I; Spanic T; Sparano J; Jezdic S; Cherny N; Curigliano G; Andre F
Ann Oncol; 2022 Jul; 33(7):702-712. PubMed ID: 35550723
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Design of Phase II Non-inferiority Trials.
Jung SH
Contemp Clin Trials Commun; 2017 Sep; 7():23-27. PubMed ID: 28798964
[TBL] [Abstract][Full Text] [Related]
5. Single-stage, three-arm, adaptive test strategies for non-inferiority trials with an unstable reference.
Brannath W; Scharpenberg M; Schmidt S
Stat Med; 2022 Nov; 41(25):5033-5045. PubMed ID: 35979723
[TBL] [Abstract][Full Text] [Related]
6. A framework for testing non-inferiority in a three-arm, sequential, multiple assignment randomized trial.
Paul E; Chakraborty B; Sikorskii A; Ghosh S
Stat Methods Med Res; 2024 Apr; 33(4):611-633. PubMed ID: 38400576
[TBL] [Abstract][Full Text] [Related]
7. Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design.
Sampayo-Cordero M; Miguel-Huguet B; Pérez-García J; Páez D; Guerrero-Zotano ÁL; Garde-Noguera J; Aguirre E; Holgado E; López-Miranda E; Huang X; Malfettone A; Llombart-Cussac A; Cortés J
Contemp Clin Trials Commun; 2020 Dec; 20():100678. PubMed ID: 33336109
[TBL] [Abstract][Full Text] [Related]
8. Design and analysis of non-inferiority mortality trials in oncology.
Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
[TBL] [Abstract][Full Text] [Related]
9. Testing superiority at interim analyses in a non-inferiority trial.
Chen YH; Chen C
Stat Med; 2012 Jul; 31(15):1531-42. PubMed ID: 22438208
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials.
Scharpenberg M; Brannath W
Stat Methods Med Res; 2023 Sep; 32(9):1784-1798. PubMed ID: 37503578
[TBL] [Abstract][Full Text] [Related]
11. Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study.
Parpia S; Thabane L; Julian JA; Whelan TJ; Levine MN
BMC Med Res Methodol; 2013 Mar; 13():44. PubMed ID: 23517401
[TBL] [Abstract][Full Text] [Related]
12. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
Li Z; Quartagno M; Böhringer S; van Geloven N
Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Impact of disinvestment from weekend allied health services across acute medical and surgical wards: 2 stepped-wedge cluster randomised controlled trials.
Haines TP; Bowles KA; Mitchell D; O'Brien L; Markham D; Plumb S; May K; Philip K; Haas R; Sarkies MN; Ghaly M; Shackell M; Chiu T; McPhail S; McDermott F; Skinner EH
PLoS Med; 2017 Oct; 14(10):e1002412. PubMed ID: 29088237
[TBL] [Abstract][Full Text] [Related]
15. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
16. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
Tang NS; Yu B; Tang ML
BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
[TBL] [Abstract][Full Text] [Related]
17. Study duration for three-arm non-inferiority survival trials designed for accrual by cohorts.
Wu Y; Li Y; Hou Y; Li K; Zhou X
Stat Methods Med Res; 2018 Feb; 27(2):507-520. PubMed ID: 26994213
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based sizing of non-inferiority trials using decision models.
Lansdorp-Vogelaar I; Jagsi R; Jayasekera J; Stout NK; Mitchell SA; Feuer EJ
BMC Med Res Methodol; 2019 Jan; 19(1):3. PubMed ID: 30612554
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
Krown SE; Moser CB; MacPhail P; Matining RM; Godfrey C; Caruso SR; Hosseinipour MC; Samaneka W; Nyirenda M; Busakhala NW; Okuku FM; Kosgei J; Hoagland B; Mwelase N; Oliver VO; Burger H; Mngqibisa R; Nokta M; Campbell TB; Borok MZ;
Lancet; 2020 Apr; 395(10231):1195-1207. PubMed ID: 32145827
[TBL] [Abstract][Full Text] [Related]
20. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
Kim CJ; Park MW; Kim MC; Choo EH; Hwang BH; Lee KY; Choi YS; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Seung KB; Jeong MH; Yim HW; Ahn Y; Chang K;
Lancet; 2021 Oct; 398(10308):1305-1316. PubMed ID: 34627490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
